EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

A Michael; C Riley; S Bokaee; M Denyer; HS Pandha; NE Annels

Back

EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

Journal article

Peer reviewed

EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

A Michael, C Riley, S Bokaee, M Denyer, HS Pandha and NE Annels

JOURNAL OF CLINICAL ONCOLOGY, Vol.29(15)

20/05/2011

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208880304124&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

30 Record Views

Details

Title: EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.
Creators: A Michael
C Riley
S Bokaee
M Denyer
HS Pandha
NE Annels
Publication Details: JOURNAL OF CLINICAL ONCOLOGY, Vol.29(15)
Publisher: AMER SOC CLINICAL ONCOLOGY
Date published: 20/05/2011
Date submitted: 17/05/2017
Identifiers: 99514642102346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

EN2: A candidate antigen for the development of targeted therapies in ovarian cancer.

Abstract

Files and links (1)

Metrics

Details

Usage Policy